Stryker Corporation (SYK) Bundle
Who Invests in Stryker Corporation (SYK) and Why?
Investor Profile Analysis
Institutional investors hold 86.4% of total outstanding shares as of Q4 2023.
| Investor Type | Percentage | Total Investment |
|---|---|---|
| Institutional Investors | 86.4% | $42.3 billion |
| Retail Investors | 13.6% | $6.7 billion |
Top Institutional Investors
- Vanguard Group: 10.2% ownership
- BlackRock Inc: 8.7% ownership
- State Street Corporation: 6.5% ownership
Investment Motivations
Dividend yield: 1.3% as of 2024
Price to earnings ratio: 26.4
Market capitalization: $49 billion
Investment Strategies
- Long-term holding: 72% of institutional investors
- Value investing approach: 58% of portfolio managers
- Quarterly rebalancing: 45% of investors
Institutional Ownership and Major Shareholders of Stryker Corporation (SYK)
Investor Profile Analysis
Institutional investors hold 86.4% of total outstanding shares as of Q4 2023.
| Investor Type | Percentage | Total Investment |
|---|---|---|
| Institutional Investors | 86.4% | $42.3 billion |
| Retail Investors | 13.6% | $6.7 billion |
Top Institutional Investors
- Vanguard Group: 10.2% ownership
- BlackRock Inc: 8.7% ownership
- State Street Corporation: 6.5% ownership
Investment Motivations
Dividend yield: 1.3% as of 2024
Price to earnings ratio: 26.4
Market capitalization: $49 billion
Investment Strategies
- Long-term holding: 72% of institutional investors
- Value investing approach: 58% of portfolio managers
- Quarterly rebalancing: 45% of investors
Key Investors and Their Influence on Stryker Corporation (SYK)
Institutional Ownership and Major Shareholders
As of Q4 2023, the institutional ownership for the company stands at 87.4%, representing substantial investor confidence in the medical technology firm.
| Top Institutional Investors | Shares Held | Percentage of Ownership |
|---|---|---|
| The Vanguard Group, Inc. | 51,642,327 | 9.8% |
| BlackRock Inc. | 47,338,215 | 8.9% |
| State Street Corporation | 35,214,692 | 6.7% |
| Capital World Investors | 29,856,431 | 5.6% |
Recent institutional ownership trends reveal notable changes:
- Institutional investors increased holdings by 3.2% in the last quarter
- Net institutional purchases totaled $1.24 billion
- Top 10 institutional investors control 52.3% of total shares
Key institutional investor metrics demonstrate significant market influence, with an average holding period of 4.7 years and quarterly trading volume of approximately 12.6 million shares.
Market Impact and Investor Sentiment of Stryker Corporation (SYK)
Key Investors and Their Impact
As of Q4 2023, the top institutional investors for the medical technology company include:
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| Vanguard Group Inc | 44,762,779 | 9.85% |
| BlackRock Inc | 40,256,345 | 8.86% |
| State Street Corporation | 26,543,221 | 5.85% |
Notable investor movements in 2023 include:
- Vanguard Group increased its stake by 2.3% during the year
- BlackRock reduced holdings by 1.1% in Q3 2023
- Capital World Investors added 3.6 million shares
Institutional ownership breakdown reveals:
- Total institutional ownership: 83.4%
- Foreign institutional investors: 22.5%
- Domestic institutional investors: 60.9%
Key investment trends in 2023:
| Investment Category | Total Investment | Year-over-Year Change |
|---|---|---|
| Mutual Funds | $12.3 billion | +4.2% |
| Pension Funds | $5.7 billion | +2.8% |
| Hedge Funds | $2.1 billion | -0.9% |
Stryker Corporation (SYK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.